Polynovo Ltd (PNV)

Currency in AUD
1.465
-0.075(-4.87%)
Delayed Data·
PNV Scorecard
Full Analysis
Impressive gross profit margins
PNV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.4601.563
52 wk Range
0.9302.510
Key Statistics
Bid/Ask
1.46 / 1.47
Prev. Close
1.54
Open
1.545
Day's Range
1.46-1.563
52 wk Range
0.93-2.51
Volume
1.64M
Average Volume (3m)
3.32M
1-Year Change
-38.89%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PNV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.975
Upside
+34.79%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Polynovo Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Polynovo Ltd Company Profile

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Compare PNV to Peers and Sector

Metrics to compare
PNV
Peers
Sector
Relationship
P/E Ratio
79.1x−7.2x−0.7x
PEG Ratio
0.530.010.00
Price/Book
12.6x2.9x2.6x
Price / LTM Sales
8.1x5.4x3.4x
Upside (Analyst Target)
30.7%60.8%36.2%
Fair Value Upside
Unlock6.2%4.1%Unlock

Analyst Ratings

6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1.975
(+34.79% Upside)

Earnings

Latest Release
Aug 25, 2025
EPS / Forecast
0.01 / 1.00
Revenue / Forecast
34.58M / --
EPS Revisions
Last 90 days

PNV Income Statement

People Also Watch

203.84
CSL
-0.89%
2.800
MSB
+8.11%
90.140
WES
-1.50%
41.81
MIN
+2.08%
14.37
WOR
+0.98%

FAQ

What Stock Exchange Does Polynovo Trade On?

Polynovo is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Polynovo?

The stock symbol for Polynovo is "PNV."

What Is the Polynovo Market Cap?

As of today, Polynovo market cap is 1.02B.

What Is Polynovo's Earnings Per Share (TTM)?

The Polynovo EPS (TTM) is 0.02.

When Is the Next Polynovo Earnings Date?

Polynovo will release its next earnings report on 02 Dec 2025.

From a Technical Analysis Perspective, Is PNV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Polynovo Stock Split?

Polynovo has split 0 times.

How Many Employees Does Polynovo Have?

Polynovo has 301 employees.

What is the current trading status of Polynovo (PNV)?

As of 07 Oct 2025, Polynovo (PNV) is trading at a price of 1.465, with a previous close of 1.54. The stock has fluctuated within a day range of 1.460 to 1.563, while its 52-week range spans from 0.930 to 2.510.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.